Model Organisms for Microbial Pathogenesis, Biofilm Formation and Antimicrobial Drug Discovery

Model Organisms for Microbial Pathogenesis, Biofilm Formation and Antimicrobial Drug Discovery

  • Busi Siddhardha
  • Madhu Dyavaiah
  • Asad Syed
Publisher:Springer NatureISBN 13: 9789811516955ISBN 10: 9811516952

Paperback & Hardcover deals ―

Amazon IndiaGOFlipkart GOSnapdealGOSapnaOnlineGOJain Book AgencyGOBooks Wagon₹13,796Book ChorGOCrosswordGODC BooksGO

e-book & Audiobook deals ―

Amazon India GOGoogle Play Books ₹167.2Audible GO

* Price may vary from time to time.

* GO = We're not able to fetch the price (please check manually visiting the website).

Know about the book -

Model Organisms for Microbial Pathogenesis, Biofilm Formation and Antimicrobial Drug Discovery is written by Busi Siddhardha and published by Springer Nature. It's available with International Standard Book Number or ISBN identification 9811516952 (ISBN 10) and 9789811516955 (ISBN 13).

This book provides essential insights into microbial pathogenesis, host-pathogen interactions, and the anti-microbial drug resistance of various human pathogens on the basis of various model organisms. The initial sections of the book introduce readers to the mechanisms of microbial pathogenesis, host-pathogen interactions, anti-microbial drug resistance, and the dynamics of biofilm formation. Due to the emergence of various microbial resistant strains, it is especially important to understand the prognosis for microbial infections, disease progression profiles, and mechanisms of resistance to antibiotic therapy in order to develop novel therapeutic strategies. In turn, the second part of the book presents a comparative analysis of various animal models to help readers understand microbial pathogenesis, host-pathogen interactions, anti-microbial drug discovery, anti-biofilm therapeutics, and treatment regimes. Given its scope, the book represents a valuable asset for microbiologists, biotechnologists, medical professionals, drug development researchers, and pharmacologists alike.